» Articles » PMID: 20073042

Reactive Oxygen Species Inhibit Adhesion of Mesenchymal Stem Cells Implanted into Ischemic Myocardium Via Interference of Focal Adhesion Complex

Overview
Journal Stem Cells
Date 2010 Jan 15
PMID 20073042
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

The integrity of transplanted mesenchymal stem cells (MSCs) for cardiac regeneration is dependent on cell-cell or cell-matrix adhesion, which is inhibited by reactive oxygen species (ROS) generated in ischemic surroundings after myocardial infarction. Intracellular ROS play a key role in the regulation of cell adhesion, migration, and proliferation. This study was designed to investigate the role of ROS on MSC adhesion. In H(2)O(2) treated MSCs, adhesion and spreading were inhibited and detachment was increased in a dose-dependent manner, and these effects were significantly rescued by co-treatment with the free radical scavenger, N-acetyl-L-cysteine (NAC, 1 mM). A similar pattern was observed on plates coated with different matrices such as fibronectin and cardiogel. Hydrogen peroxide treatment resulted in a marked decrease in the level of focal adhesion-related molecules, such as phospho-FAK and p-Src in MSCs. We also observed a significant decrease in the integrin-related adhesion molecules, alpha V and beta1, in H(2)O(2) treated MSCs. When injected into infarcted hearts, the adhesion of MSCs co-injected with NAC to the border region was significantly improved. Consequently, we observed that fibrosis and infarct size were reduced in MSC and NAC-injected rat hearts compared to in MSC-only injected hearts. These results indicate that ROS inhibit cellular adhesion of engrafted MSCs and provide evidence that the elimination of ROS might be a novel strategy for improving the survival of engrafted MSCs.

Citing Articles

Cell therapy in kidney diseases: advancing treatments for renal regeneration.

Salybekov A, Kinzhebay A, Kobayashi S Front Cell Dev Biol. 2024; 12:1505601.

PMID: 39723242 PMC: 11669058. DOI: 10.3389/fcell.2024.1505601.


Co-delivery of retinoic acid and miRNA by functional Au nanoparticles for improved survival and CT imaging tracking of MSCs in pulmonary fibrosis therapy.

Li X, Cheng S, Yu C, Li Y, Cao X, Wang Y Asian J Pharm Sci. 2024; 19(4):100944.

PMID: 39660166 PMC: 11630633. DOI: 10.1016/j.ajps.2024.100944.


Mechanistic and Kinetic Insights into Cellular Uptake of Biomimetic Dinitrosyl Iron Complexes and Intracellular Delivery of NO for Activation of Cytoprotective HO-1.

Chiu H, Chau Fang A, Chen Y, Koi R, Yu K, Hsieh L JACS Au. 2024; 4(4):1550-1569.

PMID: 38665642 PMC: 11040670. DOI: 10.1021/jacsau.4c00064.


Mesenchymal stem cell therapy in diabetic foot ulcer: An updated comprehensive review.

Hetta H, Elsaghir A, Sijercic V, Akhtar M, Gad S, Moses A Health Sci Rep. 2024; 7(4):e2036.

PMID: 38650719 PMC: 11033295. DOI: 10.1002/hsr2.2036.


Mammalian Ste20-like kinase 1 inhibition as a cellular mediator of anoikis in mouse bone marrow mesenchymal stem cells.

Zhang T, Zhang Q, Yu W World J Stem Cells. 2023; 15(3):90-104.

PMID: 37007455 PMC: 10052341. DOI: 10.4252/wjsc.v15.i3.90.